
Research Interests: risk/benefit communication, communication and visualization of quantitative information, distributional models
Publications
Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial.
– European urology
(2021)
80,
661
(DOI: 10.1016/j.eururo.2021.08.001)
How People Understand Risk Matrices, and How Matrix Design Can Improve their Use: Findings from Randomized Controlled Studies
– Risk analysis : an official publication of the Society for Risk Analysis
(2021)
(DOI: 10.1111/risa.13822)
Correlates of intended COVID-19 vaccine acceptance across time and countries: Results from a series of cross-sectional surveys
– BMJ Open
(2021)
11,
e048025
(DOI: 10.1136/bmjopen-2020-048025)
How do the UK public interpret COVID-19 test results? Comparing the impact of official information about results and reliability used in the UK, USA and New Zealand: a randomised controlled trial
– BMJ Open
(2021)
11,
e047731
(DOI: 10.1136/bmjopen-2020-047731)
How well did experts and laypeople forecast the size of the COVID-19 pandemic?
– PLoS One
(2021)
16,
e0250935
(DOI: 10.1371/journal.pone.0250935)
Communicating personalized risks from COVID-19: guidelines from an empirical study.
– Royal Society Open Science
(2021)
8,
201721
(DOI: 10.1098/rsos.201721)
COVID-19 risk perception: A longitudinal analysis of its predictors and associations with health protective behaviours in the United Kingdom
– Journal of Risk Research
(2021)
24,
294
Predictors of COVID-19 vaccine acceptance across time and countries
(2020)
(DOI: 10.1101/2020.12.09.20246439)
Communicating personalised risks from COVID-19: guidelines from an empirical study
(2020)
(DOI: 10.1101/2020.10.05.20206961)
Susceptibility to misinformation about COVID-19 around the world: Susceptibility to COVID misinformation
– R Soc Open Sci
(2020)
7,
201199
(DOI: 10.1098/rsos.201199)
- 1 of 3